Retransplantation for precore mutant-related chronic hepatitis B infection: Prolonged survival in a patient receiving sequential ganciclovir/famciclovir therapy
Open Access
- 1 November 1996
- journal article
- case report
- Published by Wiley in Liver Transplantation and Surgery
- Vol. 2 (6), 472-474
- https://doi.org/10.1002/lt.500020611
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Ganciclovir treatment of hepatitis B virus infection in liver transplant recipientsHepatology, 1996
- Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantationHepatology, 1995
- Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipientsJournal of Hepatology, 1994
- PREVENTION OF HEPATITIS B “RERECURRENCE” AFTER A SECOND LIVER TRANSPLANT—THE ROLE OF MAINTENANCE POLYCLONAL HBIG THERAPYTransplantation, 1994
- PROSTAGLANDIN E PLUS FAMCICLOVIR—A NEW CONCEPT FOR THE TREATMENT OF SEVERE HEPATITIS B AFTER LIVER TRANSPLANTATION1,2Transplantation, 1994
- In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virusAntimicrobial Agents and Chemotherapy, 1994
- Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovoJournal of Medical Virology, 1994
- RETRANSPLANTATION IN HEPATITIS B—A MULTICENTER EXPERIENCE1Transplantation, 1994
- Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infectionJournal of Gastroenterology and Hepatology, 1993
- Famciclovir and Penciclovir. The Mode of Action of Famciclovir Including Its Conversion to PenciclovirAntiviral Chemistry and Chemotherapy, 1993